KR890003385A - 항 증식제로서 유용한 5-아미노 또는 치환된 아미도 1,2,3-트리아졸 - Google Patents
항 증식제로서 유용한 5-아미노 또는 치환된 아미도 1,2,3-트리아졸 Download PDFInfo
- Publication number
- KR890003385A KR890003385A KR1019880010519A KR880010519A KR890003385A KR 890003385 A KR890003385 A KR 890003385A KR 1019880010519 A KR1019880010519 A KR 1019880010519A KR 880010519 A KR880010519 A KR 880010519A KR 890003385 A KR890003385 A KR 890003385A
- Authority
- KR
- South Korea
- Prior art keywords
- trifluoro
- cyano
- compound
- amino
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 약제학적 담체 및 치료학적 유효량의 일반식(I)의 화합물을 함유하는, 건선의 억제, 치료 및 처치용 약제학적 조성물.상기식에서,R1은[여기에서,P는 0 내지 2이고 ; m은 0 내지 4이며 ; n은 0 내지 5이고 ; X는 O,S,SO,SO2,CO,CHCN,CH2, 또는 C=NR6(여기에서, R6는 (a) 수소, (b) 저급알킬, (c) 하이드록시, (d) 저급알콕시, (e) 아미노, (f) 저급알킬아미노, (g) 디저급 알킬아미노, 또는 (h) 시아노를 나타낸다)를 나타내며, R4및 R5는 각각 독립적으로 (a) 할로겐, (b) 시아노, (c) 트리플루오로 메틸, (d) 저급 알카노일, (e) 니트로, (f) 저급알킬, (g) 저급알콕시, (h) 카복시, (i) 카브알콕시, (j) 트리플루오로 메톡시, (k) 아세트아미도, (l) 저급 알킬티오, (m) 저급알킬설피닐, (n) 저급알킬설포닐, (o) 트리클로로비닐, (p) 트리플루오로 메틸티오, (q) 트리플루오로 메틸설피닐, 또는 (r) 트리플루오로 메탈설포닐을 나타낸다]을 나타내고 ; R2는 (a) 아미노, (b) 모노 또는 디저급 알킬아미노, (c) 아세트아미도, (d) 아세트이미도, (e) 우레이도, (f) 포름아미도, (g) 포름이미도, 또는 (h) 구아니디노를 나타내며, R3는 (a) 카바모일, (b) 시아노, (c) 카바조일, (d) 아미디노, 또는 (e) N-하이드록시 카바모일을 나타낸다.
- 제1항에 있어서, n 및 m이 각각 독립적으로 0.1 또는 2이고 ; P가 1이며 ; X가 O,S,CO, 또는 CH2이고 ; R4는 (a) 플루오로, (b) 클로로, (c) 브로모, (d) 메틸, (e) 트리플루오로 메틸, (f) 시아노, (g) 카보메톡시, (h) 트리플루오로 메톡시, (i) 트리플루오로 메틸티오, (j) 니트로, 또는 (k) 트리클로로비닐을 나타내고, R5는 (a) 클로로, (b) 브로모, (c) 플루오로, (d) 메틸, (e) 트리플루오로 메틸, (f) 시아노, (g) 카브알콕시, (h) 트리클로로비닐, 또는 (i) 니트로를 나타내는 조성물.
- 제1항에 있어서, 화합물이 하기 일반식(a)을 갖는 조성물.상기식에서, X는 CH2,S,O, 또는 CO이고 ; R4는 Cl, CF3, Br 또는 CH3이며, R5는 Cl,Br, 또는 NO2이다.
- 제1항에 있어서, 화합물이 5-아미노-1-(4-[4-클로로벤조일]-3,5-디클로로벤질)-1,2,3-트리아졸-4-카복스아미드인 조성물.
- 유효량의 일반식(I)의 화합물을 건선의 치료를 필요로 하는 포유동물에게 투여하여 건선을 치료, 억제 및 처치하는 방법.상기식에서,R1은[여기에서, P는 0 내지 2이고 ; m은 0 내지 4이며 ; n은 0 내지 5이고 ; X는 O,S,SO,SO2,CO,CHCN,CH2, 또는 C=NR6(여기에서, R6는 (a) 수소, (d) 저급알킬, (e) 저급알콕시, (e) 아미노, (f) 저급알킬 아미노, (g) 디저급 알킬아미노, 또는 (h) 시아노를 나타낸다)를 나타내며, R4및 R5는 각각 독립적으로 (a) 할로겐, (b) 시아노, (c) 트리플루오로 메틸, (d) 저급 알카노일, (e) 니트로, (f) 저급알킬, (g) 저급알콕시, (h) 카복시, (i) 카브알콕시, (j) 트리플루오로 메톡시, (k) 아세트아미도, (l) 저급 알킬티오, (m) 저급알킬설피닐, (n) 저급알킬설포닐, (o) 트리클로로비닐, (p) 트리플루오로 메틸티오, (q) 트리플루오로 메틸설피닐, 또는 (r) 트리플루오로 메탈설포닐을 나타낸다]을 나타내고 ; R2는 (a) 아미노, (b) 모노 또는 디저급 알킬아미노, (c) 아세트아미도, (d) 아세트이미도, (e) 우레이도, (f) 포름아미도, (g) 포름이미도, 또는 (h) 구아니디노를 나타내며, R3는 (a) 카바모일, (b) 시아노, (c) 카바조일, (d) 아미디노, 또는 (e) N-하이드록시 카바모일을 나타낸다.
- 제5항에 있어서, 일반식(I)화합물에서 n 및 m이 각각 독립적으로 0.1 또는 2이고 ; P는 1이며 ; X는 O,S,CO, 또는 CH2이고 ; R4는 (a) 플루오로, (b) 클로로, (c) 브로모, (d) 메틸, (e) 트리플루오로 메틸, (f) 시아노, (g) 카보메톡시, (h) 트리플루오로 메톡시, (i) 트리플루오로 메틸티오, (j) 니트로, 또는 (k) 트리클로로비닐을 나타내고, R5는 (a) 클로로, (b) 브로모, (c) 플루오로, (d) 메틸, (e) 트리플루오로 메틸, (f) 시아노, (g) 카브알콕시, (h) 트리클로로비닐, 또는 (i) 니트로를 나타내는 방법.
- 제5항에 있어서, 화합물이 일반식(a)의 화합물인 방법:상기식에서, X는 CH2,S,O, 또는 CO이고 ; R4는 Cl, CF3, Br 또는 CH3이며, R5는 Cl,Br, 또는 NO2이다.
- 제5항에 있어서, 화합물이 5-아미노-1-(4-[4-클로로벤조일]-3,5-디클로로벤질)1,2,3-트리아졸-4-카복스아미드인 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US087494 | 1987-08-20 | ||
US07/087,494 US4847257A (en) | 1987-08-20 | 1987-08-20 | 5-Amino or substituted amino 1,2,3,-triazoles useful as antiproliferative agents |
US087,494 | 1987-08-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890003385A true KR890003385A (ko) | 1989-04-14 |
KR960014871B1 KR960014871B1 (ko) | 1996-10-21 |
Family
ID=22205528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880010519A KR960014871B1 (ko) | 1987-08-20 | 1988-08-19 | 5-아미노 또는 치환된 아미노 1, 2, 3-트리아졸을 포함하는, 증식억제제 및 암세포의 전이 억제제로서 유용한 약제학적 조성물 |
Country Status (16)
Country | Link |
---|---|
US (2) | US4847257A (ko) |
EP (1) | EP0304221B1 (ko) |
JP (1) | JP2572115B2 (ko) |
KR (1) | KR960014871B1 (ko) |
AT (1) | ATE101513T1 (ko) |
AU (1) | AU612172B2 (ko) |
CA (1) | CA1325977C (ko) |
CY (1) | CY1954A (ko) |
DE (1) | DE3887793T2 (ko) |
DK (1) | DK175915B1 (ko) |
HK (1) | HK107596A (ko) |
IE (1) | IE61719B1 (ko) |
IL (1) | IL87421A (ko) |
NZ (1) | NZ225770A (ko) |
PT (1) | PT88275B (ko) |
ZA (1) | ZA886125B (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5880129A (en) * | 1989-05-19 | 1999-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of inhibiting invasion and metastasis of malignant solid tumors |
US5498620A (en) * | 1989-05-19 | 1996-03-12 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor 1,2,3-triazolo compounds |
US5132315A (en) * | 1989-05-19 | 1992-07-21 | The United States Of America As Represented By The Department Of Health And Human Services | Therapeutic application of an anti-invasive compound |
US5359078A (en) * | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
JP3095413B2 (ja) * | 1990-12-28 | 2000-10-03 | 帝人株式会社 | ベンゾオキサ縮合環化合物 |
US5602156A (en) * | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
US5744492A (en) * | 1993-09-17 | 1998-04-28 | United States Of America | Method for inhibiting angiogenesis |
US5728707A (en) * | 1995-07-21 | 1998-03-17 | Constantia Gruppe | Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide |
EP0840608B1 (en) * | 1995-07-21 | 2004-10-06 | Savvipharm Inc. | Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms |
US8198334B2 (en) * | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
US7087648B1 (en) * | 1997-10-27 | 2006-08-08 | The Regents Of The University Of California | Methods for modulating macrophage proliferation using polyamine analogs |
US5886038A (en) * | 1998-03-24 | 1999-03-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
US6702801B2 (en) * | 1998-05-07 | 2004-03-09 | Kimberly-Clark Worldwide, Inc. | Absorbent garment with an extensible backsheet |
EP1799200A1 (en) * | 2004-10-04 | 2007-06-27 | Cellgate, Inc. | Polyamine analogs as therapeutic agents for ocular diseases |
US7531560B2 (en) * | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
CN101164538B (zh) * | 2006-10-16 | 2011-12-14 | 中国医学科学院基础医学研究所 | 羧胺***类化合物及其盐在制备治疗疼痛性疾病和/或炎症性疾病的药物中的应用 |
CN104817507A (zh) * | 2009-09-04 | 2015-08-05 | 巧妙疗法股份有限公司 | 用于制备5-氨基或取代的氨基1,2,3-***和***乳清酸盐制剂的新组合物和方法 |
CN112358451B (zh) * | 2021-01-11 | 2021-04-13 | 广东银珠医药科技有限公司 | 羧胺***的合成方法 |
CN113620892B (zh) * | 2021-10-12 | 2022-02-22 | 广东银珠医药科技有限公司 | 羧胺***单晶、制备方法及其组合物和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4590201A (en) * | 1984-02-02 | 1986-05-20 | Merck & Co., Inc. | 5-amino or substituted amino 1,2,3-triazoles |
-
1987
- 1987-08-20 US US07/087,494 patent/US4847257A/en not_active Expired - Lifetime
-
1988
- 1988-08-10 NZ NZ225770A patent/NZ225770A/xx unknown
- 1988-08-11 EP EP88307418A patent/EP0304221B1/en not_active Expired - Lifetime
- 1988-08-11 IL IL87421A patent/IL87421A/xx not_active IP Right Cessation
- 1988-08-11 AT AT88307418T patent/ATE101513T1/de not_active IP Right Cessation
- 1988-08-11 DE DE3887793T patent/DE3887793T2/de not_active Expired - Lifetime
- 1988-08-15 CA CA000574763A patent/CA1325977C/en not_active Expired - Fee Related
- 1988-08-16 PT PT88275A patent/PT88275B/pt not_active IP Right Cessation
- 1988-08-18 ZA ZA886125A patent/ZA886125B/xx unknown
- 1988-08-19 AU AU21159/88A patent/AU612172B2/en not_active Expired
- 1988-08-19 KR KR1019880010519A patent/KR960014871B1/ko not_active IP Right Cessation
- 1988-08-19 IE IE255188A patent/IE61719B1/en not_active IP Right Cessation
- 1988-08-19 DK DK198804654A patent/DK175915B1/da not_active IP Right Cessation
- 1988-08-20 JP JP63205715A patent/JP2572115B2/ja not_active Expired - Fee Related
-
1989
- 1989-05-08 US US07/348,823 patent/US5045543A/en not_active Expired - Lifetime
-
1996
- 1996-06-19 HK HK107596A patent/HK107596A/xx not_active IP Right Cessation
-
1997
- 1997-05-16 CY CY195497A patent/CY1954A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL87421A0 (en) | 1989-01-31 |
EP0304221A2 (en) | 1989-02-22 |
CY1954A (en) | 1997-05-16 |
US4847257A (en) | 1989-07-11 |
EP0304221A3 (en) | 1990-09-05 |
IE61719B1 (en) | 1994-11-30 |
DE3887793D1 (de) | 1994-03-24 |
JP2572115B2 (ja) | 1997-01-16 |
CA1325977C (en) | 1994-01-11 |
ATE101513T1 (de) | 1994-03-15 |
AU612172B2 (en) | 1991-07-04 |
US5045543A (en) | 1991-09-03 |
NZ225770A (en) | 1991-11-26 |
DK175915B1 (da) | 2005-06-27 |
JPS6468321A (en) | 1989-03-14 |
HK107596A (en) | 1996-06-28 |
EP0304221B1 (en) | 1994-02-16 |
DK465488D0 (da) | 1988-08-19 |
KR960014871B1 (ko) | 1996-10-21 |
PT88275B (pt) | 1995-03-01 |
ZA886125B (en) | 1989-04-26 |
IE882551L (en) | 1989-02-20 |
DK465488A (da) | 1989-03-15 |
DE3887793T2 (de) | 1994-07-28 |
AU2115988A (en) | 1989-03-16 |
IL87421A (en) | 1992-12-01 |
PT88275A (pt) | 1989-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890003385A (ko) | 항 증식제로서 유용한 5-아미노 또는 치환된 아미도 1,2,3-트리아졸 | |
DK0675886T3 (da) | Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister | |
ATE156482T1 (de) | 1,4,5-triphenyl-pyrazolverbindungen zur behandlumg von entzündungen und entzündungsverwandten störungen | |
TR199701667T2 (xx) | �ift �evrimli amino t�revleri ve bu t�revleri i�eren PGD2 antogonisti. | |
DE69329727T2 (de) | Neue imidazol derivate, ihre herstellung und therapeutische verwendung | |
FI932229A0 (fi) | Azabicykliska bryggderivat | |
ES2190430T3 (es) | Nuevas sulfonamidas. | |
ATE67489T1 (de) | 5-(amino- oder subst. amino-)1,2,3-triazole. | |
ATE29265T1 (de) | Neue redox-indikatoren. | |
DK0530505T3 (da) | Hydantoinderivater | |
MX9305894A (es) | Azaquinoxalinas, procedimientos para su preparacion y su empleo. | |
BR1100086A (pt) | Derivados de fluoralcóxibenzilamino de heterocìclos contendo nitrogênio | |
ATE212343T1 (de) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren | |
ES2177581T3 (es) | Uso de compuestos de piperidina en el tratamiento de esquizofrenia. | |
SE8301608D0 (sv) | /1-(2-bensoxazolyl)hydrazino/alkylnitrilderivat | |
KR900011754A (ko) | (디-3급-부틸히드록시페닐)티오 유도체 | |
ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
FI945975A (fi) | Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
ES2179254T3 (es) | 1-poliarilpirazoles plaguicidas. | |
RU95106653A (ru) | Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе | |
ES450012A1 (es) | Procedimiento de preparacion de nuevos derivados fenoxi y de sus sales de adicion con acidos minerales u organicos. | |
AU8551482A (en) | Azole fungicides | |
KR880011149A (ko) | N-1h-테트라졸-5-일-2-티오펜카르복사미드, n-1h-테트라졸-5-일-2-피롤카르복사미드,n-1h-테트라졸-5-일-2-푸란 카르복사미드 | |
FI960588A0 (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20060929 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |